Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
28
Number of overlapping holdings
12.5%
% of IBB's 261 holdings also in FBT
93.3%
% of FBT's 31 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.2% | 4.3% | 4.3% |
|
VERTEX PHARMACEUTICALS INC | 8.6% | 4.2% | 4.2% |
|
AMGEN INC | 8.4% | 4.1% | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 3.9% | 3.6% |
|
REGENERON PHARMACEUTICALS | 7.3% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to FBT
|
VERTEX PHARMACEUTICALS INC | 4.5% |
|
AMGEN INC | 4.3% |
|
REGENERON PHARMACEUTICALS | 4.2% |
|
GILEAD SCIENCES INC | 3.9% |
|
IQVIA HOLDINGS INC | 3.4% |
|
INSMED INC | 1.5% |
|
BIO-TECHNE CORPORATION | 1.0% |
|
VAXCYTE, INC. | 0.9% |
|
CHARLES RIVER LABORATORIES | 0.9% |
|
MEDPACE HOLDINGS, INC. | 0.9% |
IBB Underweight Relative to FBT
|
CORCEPT THERAPEUTICS INC | -3.8% |
|
BEIGENE LTD. SPONSORED ADR | -3.6% |
 |
ALKERMES PLC | -3.5% |
|
INTRA-CELLULAR THERAPIES INC | -3.4% |
|
HALOZYME THERAPEUTICS INC | -3.3% |
|
ACADIA PHARMACEUTICALS INC | -3.1% |
|
EXACT SCIENCES CORP | -2.7% |
|
EXELIXIS INC | -2.4% |
|
VERACYTE INC | -2.3% |
|
REPLIGEN CORP | -2.2% |